Debiopharm Innovation Fund

Debiopharm Innovation Fund - also known as Debiopharm Diagnostics - is the venture capital subsidiary of Debiopharm Group. The firm has been in operations since 2008. It specializes in funding companies that are developing smart data and digital health products and services intended for drug development and patient journey in the field of oncology and infectious diseases. Debiopharm Innovation Fund prefers to fund companies during the Series A and B financing round. As of January 2020, Debiopharm Innovation Fund has invested in 19 companies and has sold off its stakes in eight of them.